TheStreet.com Ratings provides exclusive stock, ETF and mutual fund recommendations using proprietary tools. Our "safety first" approach aims to reduce risk while achieving total return performance.

BOSTON (

TheStreet

) -- The following companies are projected to increase revenue and profit by at least 12% in the coming year and receive "buy" ratings from our quantitative model, which considers more than 60 factors. They're ordered by their potential to appreciate, starting with the company with the best growth prospects.

Lance

(LNCE)

makes snack foods, including Cape Cod Potato Chips and Archway Cookies.

The numbers

: Second-quarter net income surged 252% to $9.5 million and earnings per share grew 233% to 30 cents, restrained by a higher share count. Revenue grew 11% to $237 million. Its gross margin jumped from 41% to 44% and its operating margin rose from 3% to 7%. A quick ratio of 1.1 indicates adequate liquidity. A debt-to-equity ratio of 0.4 demonstrates conservative leverage.

The stock

: Lance has advanced 16% this year, beating the

Dow Jones Industrial Average

, but trailing the

S&P 500 Index

. The stock trades at a price-to-earnings ratio of 28, a premium to the market and packaged food peers. Shares pay a 2.4% dividend yield.

Strayer Education

(STRA) - Get Report

runs various for-profit academic programs.

The numbers

: Second-quarter net income increased 29% to $28 million and earnings per share climbed 33% to $1.50. Revenue grew 29% to $126 million. Its gross margin rose from 69% to 70% and its operating margin ascended from 34% to 35%. The company has an ideal financial position, with $90 million of cash and no debt.

The stock

: Strayer is up 6% this year, trailing major U.S. indices. The stock trades at a price-to-earnings ratio of 34, a premium to the market and education service peers. Shares pay a 0.9% dividend yield.

Lincoln Educational Services

(LINC) - Get Report

provides career-oriented education services.

The numbers

: Second-quarter profit surged six-fold to $7.4 million and earnings per share multiplied five-fold to 27 cents, restrained by a higher share count. Revenue grew 51% to $128 million. Its gross margin rose from 63% to 65% and its operating margin increased from 3% to 11%. The company has less-than-ideal liquidity, with just $13 million of cash reserves. A debt-to-equity ratio of 0.2 indicates modest leverage.

The stock

: Lincoln Educational Services has advanced 76% this year, beating major U.S. indices. The stock trades at a price-to-earnings ratio of 19, a discount to the market and education service peers. The company doesn't pay dividends.

Medco Health Solutions

(MHS)

is one of the largest pharmacy-benefit managers in the U.S.

The numbers

: Second-quarter net income rose 19% to $312 million and earnings per share jumped 26% to 64 cents, boosted by a lower share count. Revenue increased 17% to $15 billion. Its gross margin was little changed at 7% and its operating margin remained steady at 4%. Medco has less-than-ideal liquidity, reflected in its quick ratio of 0.9. A debt-to-equity ratio of 0.8 indicates reasonable leverage.

The stock

: Medco has advanced 35% this year, beating the Dow and S&P 500. The stock trades at a price-to-earnings ratio of 24, a premium to the market and health care peers. The company doesn't pay dividends.

Teva Pharmaceuticals

(TEVA) - Get Report

is an Israeli pharmaceutical company.

The numbers

: Second-quarter net income dropped 2% to $521 million and earnings per share fell 11% to 58 cents, hurt by a higher share count. Revenue ascended 20% to $3.4 billion. Its gross margin dropped from 58% to 54%, but its operating margin increased from 23% to 24%. A quick ratio of 0.9 indicates less-than-ideal liquidity. A debt-to-equity ratio of 0.4 reflects conservative leverage.

The stock

: Teva is up 18% this year, beating the Dow, but lagging behind the S&P 500. The stock trades at a price-to-earnings ratio of 52, a premium to the market and pharmaceutical peers. Shares pay a 1.2% dividend yield.

-- Reported by Jake Lynch in Boston.